ARCHIVES

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

This article is from The Cancer Letter archive.

Vol. 20 No. 06 | February 11, 1994

Download PDF Visit The Full Archive

Related Articles

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

September 26, 1980

Kurzrock and Ferrara Join UCSD Moores Cancer Center

January 25, 2013

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994